FibroGen Stock Target Price and Analyst Consensus
FGEN Stock | USD 2.35 0.23 8.91% |
The current analyst and expert consensus on FibroGen is Hold, with 0 strong buy opinions. The current projected FibroGen target price consensus is 2.17 with 3 analyst opinions. The most common way FibroGen analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview FibroGen executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on FibroGen. We encourage you to use your own analysis of FibroGen to validate this buy or sell advice. FibroGen buy-or-sell recommendation module provides average expert sentiment on the projected FibroGen target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on FibroGen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.
Lowest Forecast 1.97 | Highest Forecast 2.41 | Target Price 2.17 |
FibroGen |
It's important to approach FibroGen's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
FibroGen Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. FibroGen target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. FibroGen's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
3 | Hold |
Most FibroGen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand FibroGen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of FibroGen, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationFibroGen Target Price Projection
FibroGen's current and average target prices are 2.35 and 2.17, respectively. The current price of FibroGen is the price at which FibroGen is currently trading. On the other hand, FibroGen's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On FibroGen Target Price
FibroGen Analyst Ratings
FibroGen's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about FibroGen stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of FibroGen's financials, market performance, and future outlook by experienced professionals. FibroGen's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize FibroGen price targets
FibroGen's stock target price is an estimate of its future price, usually made by analysts. Using FibroGen's target price to determine if it is a suitable investment can be done through the following steps:- Look at FibroGen's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if FibroGen's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional FibroGen Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of FibroGen is a key component of FibroGen valuation and have some predictive power on the future returns of a FibroGen.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of FibroGen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Cleaning Invested over 100 shares | ||
Business Services Invested few shares | ||
Macroaxis Index Invested over 200 shares | ||
Baby Boomer Prospects Invested over 40 shares | ||
Check out Macroaxis Advice on FibroGen to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
The data published in FibroGen's official financial statements usually reflect FibroGen's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of FibroGen. For example, before you start analyzing numbers published by FibroGen accountants, it's critical to develop an understanding of what FibroGen's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of FibroGen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, FibroGen's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in FibroGen's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of FibroGen. Please utilize our Beneish M Score to check the likelihood of FibroGen's management manipulating its earnings.